Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-04-0234PMID 15767549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide Microarrays

  2004cited by this paper
• Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes

  2004cited by this paper
• Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.

  2004cited by this paper
• Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics

  2003cited by this paper
• Chemosensitivity of human pancreatic carcinoma cells is enhanced by IkappaBalpha super-repressor.

  2003cited by this paper
• Chemosensitivity of human pancreatic carcinoma cells is enhanced by IkBα super‐repressor

  2003cited by this paper
• Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines

  2003cited by this paper
• Tumour cytochrome P450 and drug activation.

  2002influential reference
• An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.

  2002cited by this paper
• Arylamine N-acetyltransferases and drug response.

  2002cited by this paper
• Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis.

  2002cited by this paper
• Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs.

  2002cited by this paper
• Mechanisms of resistance to cisplatin.

  2001cited by this paper
• Telomerase activity is repressed during differentiation along the hepatocytic and biliary epithelial lineages: verification on immortal cell lines from the same origin

  2001cited by this paper
• Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

  2000cited by this paper
• A gene expression database for the molecular pharmacology of cancer

  2000influential reference
• Control of mRNA decay by heat shock-ubiquitin-proteasome pathway.

  1999cited by this paper
• Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel.

  1999cited by this paper
• Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.

  1997cited by this paper
• An Information-Intensive Approach to the Molecular Pharmacology of Cancer

  1997cited by this paper
• A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.

  1996cited by this paper
• A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice.

  1996influential reference
• Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicumarol.

  1992cited by this paper
• Neural computing in cancer drug development: predicting mechanism of action.

  1992cited by this paper
• Mechanisms of resistance to cisplatin.

  1991cited by this paper
• Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.

  1991influential reference
• Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins.

  1990cited by this paper
• Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines.

  1990influential reference
• Production of transforming growth factor-α in human tumor cell lines

  1989influential reference
• Production of transforming growth factor-alpha in human tumour cell lines.

  1989cited by this paper
• Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

  1989cited by this paper
• Requirement of serum pretreatment for induction of alkaline phosphatase activity with prednisolone, butyrate, dibutyryl cyclic adenosine monophosphate and NaCl in human liver cells continuously cultured in serum-free medium.

  1988influential reference
• Fluorouracil: biochemistry and pharmacology.

  1988cited by this paper
• Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

  1986influential reference
• Methotrexate resistance and gene amplification. Mechanisms and implications

  1986cited by this paper
• Production of fibronectin by HUH6 C15 cell line established from a human hepatoblastoma.

  1983influential reference
• Processing of prolactin by human breast cancer cells in long term tissue culture.

  1980influential reference
• Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.

  1978cited by this paper
• The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA)

  1977cited by this paper
• Establishment and some biological characteristics of human hepatoma cell lines.

  1975influential reference
• Synthesis and biological evaluation of poly-gamma-glutamyl derivatives of methotrexate.

  1973cited by this paper

• Systematic Review of Comparative Transcriptomic Studies of Cellular Resistance to Genotoxic Stress.

  2023cites this paper
• Debiased inference for heterogeneous subpopulations in a high-dimensional logistic regression model

  2023cites this paper
• Passage number of cancer cell lines: Importance, intricacies, and way‐forward

  2023cites this paper
• Establishment of a New Cell Line of Canine Inflammatory Mammary Cancer: IMC-118.

  2022cites this paper
• In Vitro Human Cancer Models for Biomedical Applications

  2022cites this paper
• Cytotoxic Activity of Carica papaya L. Leaf Ethanolic Extract and Fractions Against Artemia salina Nauplii

  2021cites this paper
• A gentle introduction to understanding preclinical data for cancer pharmaco-omic modeling

  2021cites this paper
• Investigation on the Anticancer Activity of Symmetric and Unsymmetric Cyclic Sulfamides.

  2021cites this paper
• The LL-100 Cell Lines Panel: Tool for Molecular Leukemia–Lymphoma Research

  2020cites this paper
• The LL-100 panel: 100 cell lines for blood cancer studies

  2019cites this paper
• Estimation of anticancer effect of methanolic extract of Artemisia herba alba on human cancer cell lines

  2019cites this paper
• In-vitro Morphological Assessment of Apoptosis Induced by Nimbolide; A Limonoid from Azadirachta Indica (Neem Tree)

  2019cites this paper
• The effect of aqueous and ethanolic extracts of Sedum album L. on human stomach and breast carcinoma cell lines in vitro

  2019cites this paper
• Identification of commonly regulated protein targets and molecular pathways in PC-3 and DU145 androgen-independent human prostate cancer cells treated with the curcumin analogue 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one

  2018cites this paper
• Design, synthesis and molecular modeling study of certain 4-Methylbenzenesulfonamides with CDK2 inhibitory activity as anticancer and radio-sensitizing agents.

  2018cites this paper
• Functional Data Analysis: Omics for Environmental Risk Assessment

  2018cites this paper
• Challenging transcription by DNA‐binding antitumor drugs

  2018cites this paper
• Human Cancer Cell Lines: Potential to Evaluate the Therapeutic Efficacy of Anticancer Agents

  2017cites this paper
• In vitro comparative models for canine and human breast cancers

  2016cites this paper
• Synthesis and cytotoxic effect on RD cell line of Pd(II) and Cu(II)

  2016cites this paper
• Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents.

  2016cites this paper
• Using Human Cancer Cell Lines as In vitro Model for Testing the Efficacyof CDBPA; a New Anticancer Drug

  2016cites this paper
• Anticancer Potential of Sterols Isolated from Turbinaria conoides Against Lung and Liver Cancer

  2016cites this paper
• Molecular classification and prediction in gastric cancer

  2015cites this paper
• Comparative Chemosensitivity of VX2 and HCC Cell Lines to Drugs Used in TACE.

  2015cites this paper
• Evaluation of In-vitro Anti-cancer activity of Ethanolic Extract of Corallocarpus epigaeus on Chronic Myeloid Leukaemia K562 Cell lines

  2015cites this paper
• Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.

  2015cites this paper
• Avaliação do efeito citotóxico de piranonaftoquinonas inibidoras de DNA topoisomerases sobre células de leucemia

  2015cites this paper
• Identifying therapeutic targets by elucidating signaling pathways in pediatric lymphoid leukemias

  2015cites this paper
• Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.

  2014cites this paper
• Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines

  2014cites this paper
• Novel target genes responsive to apoptotic activity by Ocimum gratissimum in human osteosarcoma cells.

  2014cites this paper
• Prediction of individual response to anticancer therapy: historical and future perspectives

  2014cites this paper
• Two Faces of Cathepsin D: Physiological Guardian Angel and Pathological Demon

  2014cites this paper
• The Importance of Cancer Cell Lines as in vitro Models in Cancer Methylome Analysis and Anticancer Drugs Testing

  2013influential citation
• Oncogenomics and Cancer Proteomics – Novel Approaches in Biomarkers Discovery and Therapeutic Targets in Cancer 140 2 . Cancer cell lines as a model for cancer study

  2013influential citation
• Chemical genomics for studying parasite gene function and interaction.

  2013cites this paper
• Neural stem cells—trends and advances

  2013cites this paper
• Chemical Biological Studies on the Regulatory Mechanism of Tumor Cell Migration

  2013cites this paper
• Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics

  2013cites this paper
• Maspin: molecular mechanisms and therapeutic implications

  2012cites this paper
• A chemical genomic study identifying diversity in cell migration signaling in cancer cells

  2012cites this paper
• Integrating Constitutive Gene Expression and Chemoactivity: Mining the NCI60 Anticancer Screen

  2012cites this paper
• The stellate cancer-associated fibroblast in pancreatic ductal adenocarcinoma : its role in chemoresistance

  2012cites this paper
• Prediction of drug efficacy for cancer treatment based on comparative analysis of chemosensitivity and gene expression data.

  2012cites this paper
• 2-Anilinonicotinyl linked 1,3,4-oxadiazole derivatives: Synthesis, antitumour activity and inhibition of tubulin polymerization

  2011cites this paper
• Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysis

  2011cites this paper
• A novel approach for tumor sensitivity prediction and combination therapy design for targeted drugs

  2011cites this paper
• Identification and Replication of Loci Involved in Camptothecin-Induced Cytotoxicity Using CEPH Pedigrees

  2011cites this paper
• An integrative approach to identifying cancer chemoresistance-associated pathways

  2011cites this paper
• The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds

  2011cites this paper
• Cytochrome P450 1B1 Gene Polymorphisms as Predictors of Anticancer Drug Activity: Studies with In vitro Models

  2010cites this paper
• Reinventing Diagnostics for Personalized Therapy in Oncology

  2010cites this paper
• Development of a system to predict molecular targets of novel compounds: its application to anticancer drug discovery (Symposium in the 26th annual meeting of Medical and Pharmaceutical Society for Wakan-Yaku: Molecular science and Kampo medicine)

  2010cites this paper
• Preclinical Development Cytochrome P 450 1 B 1 Gene Polymorphisms as Predictors of Anticancer Drug Activity : Studies with In vitro Models

  2010cites this paper
• Integrative Functional Genomics in Cancer Research and Its Clinical Implications

  2010cites this paper
• Two Lung Masses with Different Responses to Pemetrexed

  2010cites this paper
• Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents

  2010cites this paper
• Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma.

  2010cites this paper
• Identification of candidate genes determining chemosensitivity to anti-cancer drugs of gastric cancer cell lines.

  2009cites this paper
• Expression levels of p18 INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines

  2009cites this paper
• The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models

  2009influential citation
• Expression levels of p 18 INK 4 C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines

  2009cites this paper
• Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer.

  2009cites this paper
• Expression levels of p18INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines

  2009cites this paper
• Possible chemical mechanisms underlying the antitumor activity of S-deoxyleinamycin.

  2008cites this paper
• Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents.

  2008cites this paper
• A structural analysis of the differential cytotoxicity of chemicals in the NCI-60 cancer cell lines.

  2008cites this paper
• Pharmacogenomics of the National Cancer Institute’s 60-Tumor Cell Panel

  2008cites this paper
• TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma

  2008influential citation
• Gene expression patterns within cell lines are predictive of chemosensitivity

  2008cites this paper
• Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.

  2007cites this paper
• Identification of JTP‐70902, a p15INK4b‐inductive compound, as a novel MEK1/2 inhibitor

  2007cites this paper
• Cross platform microarray analysis for robust identification of differentially expressed genes

  2007cites this paper
• Evaluation of Action Mechanisms of Toxic Chemicals Using JFCR39, a Panel of Human Cancer Cell Lines

  2007cites this paper
• Gene expression profiles as biomarkers for the prediction of chemotherapy drug response in human tumour cells.

  2007cites this paper
• Induction of endoplasmic reticulum stress by the pro-apoptotic retinoid N-(4-Hydroxyphenyl)retinamide via a reactive oxygen species-dependent mechanism in human head and neck cancer cells

  2007cites this paper
• Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer.

  2007cites this paper
• Synthesis of a new class of 2-anilino substituted nicotinyl arylsulfonylhydrazides as potential anticancer and antibacterial agents.

  2007cites this paper
• Potential and cytotoxicity of cis-platinum complex with anti-tumor activity in combination therapy.

  2006cites this paper
• The NCI60 human tumour cell line anticancer drug screen

  2006cites this paper
• Modification of pyrimidine derivatives from antiviral agents to antitumor agents.

  2006cites this paper
• Evaluating Chemical Structure Similarity as an Indicator of Cellular Growth Inhibition

  2006cites this paper
• Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action

  2005cites this paper